Live from the NIH registry
Studies recruiting near Greenville right now
Top 25 of 382 recruiting studies, sorted by proximity — each links to its official registry page
S1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Receptor Positive Her2 Negative Metastatic Breast Cancer
Anatomic Stage IV Breast Cancer AJCC v8, Estrogen Receptor Positive
N/A
Interventional 739 participants sought
Prisma Health Cancer Institute - Butternut — Greenville, South Carolina (2.0 mi)
· Sponsor: SWOG Cancer Research Network
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
Ovarian Carcinoma
N/A
Interventional 1,956 participants sought
Prisma Health Cancer Institute - Faris — Greenville, South Carolina (2.0 mi)
· Sponsor: NRG Oncology
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
Prostate Adenocarcinoma, Stage III Prostate Cancer AJCC v8
Phase 3
Interventional 1,500 participants sought
Gibbs Cancer Center-Pelham — Greer, South Carolina (10.6 mi)
· Sponsor: NRG Oncology
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Previously Treated Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 10,000 participants sought
BI-LO Charities Children's Cancer Center — Greenville, South Carolina (2.0 mi)
· Sponsor: SWOG Cancer Research Network
Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma
Smoldering Plasma Cell Myeloma
Phase 3
Interventional 288 participants sought
Prisma Health Cancer Institute - Butternut — Greenville, South Carolina (2.0 mi)
· Sponsor: ECOG-ACRIN Cancer Research Group
Registry of Patients With a Diagnosis of Spinal Muscular Atrophy (SMA)
Spinal Muscular Atrophy (SMA)
N/A
Observational 700 participants sought
Prisma Health — Greenville, South Carolina (2.0 mi)
· Sponsor: Novartis Pharmaceuticals
A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
Non Small Cell Lung Cancer, c-MET
Phase 3
Interventional 768 participants sought
St Francis Cancer Center /ID# 243596 — Greenville, South Carolina (2.0 mi)
· Sponsor: AbbVie
A Study to Investigate Subcutaneous Isatuximab in Combination With Weekly Carfilzomib and Dexamethasone in Adult Participants With Relapsed and/or Refractory Multiple Myeloma
Plasma Cell Myeloma Refractory
Phase 2
Interventional 64 participants sought
Prisma Health Cancer Institute - Greenville- Site Number : 8400019 — Greenville, South Carolina (2.0 mi)
· Sponsor: Sanofi
NV PSR INSPIRE-A Pipeline™ Vantage Post Approval Study
Intracranial Aneurysm
N/A
Observational 118 participants sought
Prisma Health — Greenville, South Carolina (2.0 mi)
· Sponsor: Medtronic Neurovascular Clinical Affairs
A Study of Patients With Lower Extremity Acute Limb Ischemia to Remove Thrombus With the Indigo™ Aspiration System (STRIDE II)
Lower Extremity Acute Limb Ischemia, LE ALI
N/A
Observational 300 participants sought
Prisma Health Greenville Memorial Hospital — Greenville, South Carolina (2.0 mi)
· Sponsor: Penumbra Inc.
Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention
Percutaneous Coronary Intervention, Peripheral Endovascular Intervention
Phase 4
Interventional 6,000 participants sought
AnMed Health Medical Center — Anderson, South Carolina (28.1 mi)
· Sponsor: Duke University
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
Breast Neoplasms, Triple Negative Breast Neoplasms
Phase 3
Interventional 2,400 participants sought
St Francis Cancer Center ( Site 0093) — Greenville, South Carolina (2.0 mi)
· Sponsor: Merck Sharp & Dohme LLC
A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients With Low-Grade Glioma
Low Grade Astrocytoma, Low Grade Glioma
Phase 3
Interventional 170 participants sought
BI-LO Charities Children's Cancer Center — Greenville, South Carolina (2.0 mi)
· Sponsor: National Cancer Institute (NCI)
C-Brace Prospective Registry
Pareses, Lower Extremity
N/A
Observational 250 participants sought
Carolina Ottobock.care — Spartanburg, South Carolina (25.8 mi)
· Sponsor: Otto Bock Healthcare Products GmbH
A Study of Treatment for Medulloblastoma Using Sodium Thiosulfate to Reduce Hearing Loss
Childhood Medulloblastoma
Phase 3
Interventional 225 participants sought
BI-LO Charities Children's Cancer Center — Greenville, South Carolina (2.0 mi)
· Sponsor: Children's Oncology Group
A Phase 2/3 Study of Osivelotor in Adult and Adolescent Participants With SCD
Sickle Cell Disease
Phase 2, Phase 3
Interventional 389 participants sought
Prisma Health - Upstate — Greenville, South Carolina (2.0 mi)
· Sponsor: Pfizer
A Multicenter, Postmarket Surveillance Study of Subjects With the Canary canturioTM te Tibial Extension
Knee Osteoarthritis
N/A
Observational 626 participants sought
Carolina Orthopaedic & Neurosurgical Associates — Spartanburg, South Carolina (25.8 mi)
· Sponsor: Canary Medical
A Phase 3 Study of Revaccination in Subsequent Pregnancies With Bivalent RSV Vaccine and Duration of Protection of a Single Dose
RSV Infection
Phase 3
Interventional 550 participants sought
Prisma Health Maternal Fetal Medicine — Greenville, South Carolina (2.0 mi)
· Sponsor: Pfizer
STEPS: Substance Use Trial of E-cigarettes or Pharmacotherapy for Smoking
Tobacco Use, Substance Use Disorders
N/A
Interventional 240 participants sought
Phoenix Center — Greenville, South Carolina (2.0 mi)
· Sponsor: Medical University of South Carolina
Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)
Type 2 Diabetes, Cortisol Excess
Phase 2
Interventional 1,500 participants sought
Velocity Clinical Research, Anderson — Anderson, South Carolina (28.1 mi)
· Sponsor: Sparrow Pharmaceuticals
Product Surveillance Registry
Cardiac Rhythm Disorders, Urological Disorders
N/A
Observational 100,000 participants sought
Research site — Spartanburg, South Carolina (25.8 mi)
· Sponsor: Medtronic
Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)
Solid Tumors, Hematologic Malignancies
Phase 3
Interventional 3,500 participants sought
Saint Francis Health System ( Site 0089) — Greenville, South Carolina (2.0 mi)
· Sponsor: Merck Sharp & Dohme LLC
Collection of Research Data and Samples From Patients Treated With Immunotherapy to Study Its Side Effects
Hematopoietic and Lymphoid Cell Neoplasm, Immune System Disorder
N/A
Observational 2,240 participants sought
Saint Francis Hospital — Greenville, South Carolina (2.0 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
A Study of ASP1002 in Adults for Treatment of Solid Tumors
Advanced Solid Tumors
Phase 1
Interventional 798 participants sought
Prisma Health-Upstate Cancer Institute — Greenville, South Carolina (2.0 mi)
· Sponsor: Astellas Pharma Global Development, Inc.
Evaluation of Tirzepatide as an Adjunct to Buprenorphine for the Treatment of Opioid Use Disorder
Opioid Use Disorder, Opioid Use Disorder, Moderate
Phase 2
Interventional 310 participants sought
Prisma Health — Greenville, South Carolina (2.0 mi)
· Sponsor: T. John Winhusen, PhD